AU6235799A - New use - Google Patents

New use

Info

Publication number
AU6235799A
AU6235799A AU62357/99A AU6235799A AU6235799A AU 6235799 A AU6235799 A AU 6235799A AU 62357/99 A AU62357/99 A AU 62357/99A AU 6235799 A AU6235799 A AU 6235799A AU 6235799 A AU6235799 A AU 6235799A
Authority
AU
Australia
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62357/99A
Inventor
Ignacio Arencibia
Karl-Gosta Sundqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KARL GOSTA SUNDQVIST
Original Assignee
KARL GOSTA SUNDQVIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9803098A external-priority patent/SE9803098D0/en
Application filed by KARL GOSTA SUNDQVIST filed Critical KARL GOSTA SUNDQVIST
Publication of AU6235799A publication Critical patent/AU6235799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU62357/99A 1998-09-10 1999-09-08 New use Abandoned AU6235799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9803098 1998-09-10
SE9803098A SE9803098D0 (en) 1998-09-10 1998-09-10 new use
US13579899P 1999-05-24 1999-05-24
US60135798 1999-05-24
PCT/SE1999/001560 WO2000015175A2 (en) 1998-09-10 1999-09-08 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells

Publications (1)

Publication Number Publication Date
AU6235799A true AU6235799A (en) 2000-04-03

Family

ID=26663397

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62357/99A Abandoned AU6235799A (en) 1998-09-10 1999-09-08 New use

Country Status (4)

Country Link
EP (1) EP1112078A2 (en)
JP (1) JP2003527307A (en)
AU (1) AU6235799A (en)
WO (1) WO2000015175A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037313A2 (en) 2003-10-17 2005-04-28 University Court Of The University Of Edinburgh Tissue repair by modulation of beta-1 integrin biological function
WO2006095267A1 (en) * 2005-03-10 2006-09-14 Institut Pasteur Compositions for the treatment of tumour pathologies, comprising internalin b (in1b) of listeria monocytogene protein or a fragment thereof
JP2007008895A (en) * 2005-07-04 2007-01-18 Chugai Pharmaceut Co Ltd Combined use of anti-cd47 antibody and integrin ligand
GB0703652D0 (en) 2007-02-26 2007-04-04 Univ Bradford Method for the allosteric modulation of beta1 integrin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013250A1 (en) * 1994-10-27 1996-05-09 Amgem Inc. Compositions for increased bioavailability of orally delivered therapeutic agents
US5846536A (en) * 1996-10-04 1998-12-08 The Regents Of The University Of California Restoration of normal phenotype in cancer cells

Also Published As

Publication number Publication date
JP2003527307A (en) 2003-09-16
WO2000015175A2 (en) 2000-03-23
EP1112078A2 (en) 2001-07-04
WO2000015175A3 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU5970699A (en) Use
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AUPP584198A0 (en) New use
AU5407599A (en) Sphingolipid-desaturase
AU3253699A (en) Myxochelines
AU8363398A (en) Capotasto
AU5998199A (en) New bis-benzimidazoles
AU2609599A (en) Sensor-coupling
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU6235799A (en) New use
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU5223199A (en) Bathtub-bathseat
AU3819799A (en) Methoximinomethyloxathiazines
AU2840799A (en) 1-phosphanorbornadienes
AU4813399A (en) New use
AU4812199A (en) New use
AUPP282798A0 (en) New use
AUPP195598A0 (en) New use
AU3056399A (en) New use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase